Differences in incidence and trends of haematological malignancies in Japan and the United States

British Journal of Haematology

Volumn 164, Issue 4, 2014, Pages 536-545

  Chihara, Dai ^a   Ito, Hidemi ^a   Matsuda, Tomohiro ^b   Shibata, Akiko ^b   Katsumi, Akira ^c   Nakamura, Shigeo ^d   Tomotaka, Sobue ^e   Morton, Lindsay M ^f   Weisenburger, Dennis D ^g   Matsuo, Keitaro ^a,h  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f NATIONAL CANCER INSTITUTE   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h KYUSHU UNIVERSITY   (Japan)

Author keywords

Haematological malignancies; Incidence; Japan; Surveillance epidemiology and end results; Trend

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER INCIDENCE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL EVALUATION; CUTANEOUS T CELL LYMPHOMA; ENVIRONMENTAL EXPOSURE; FEMALE; HODGKIN DISEASE; HUMAN; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; TREND STUDY; UNITED STATES;

HAEMATOLOGICAL MALIGNANCIES; INCIDENCE; JAPAN; SURVEILLANCE EPIDEMIOLOGY AND END RESULTS; TREND;

FEMALE; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; INCIDENCE; JAPAN; LYMPHOMA, NON-HODGKIN; MALE; REGISTRIES; UNITED STATES;

EID: 84892955332     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12659     Document Type: Article

References (37)

1. Anderson, J.R., Armitage, J.O. & Weisenburger, D.D. (1998) Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Annals of oncology, 9, 717-720.
2. Bray, F., Guilloux, A., Sankila, R. & Parkin, D.M. (2002) Practical implications of imposing a new world standard population. Cancer causes & control: CCC, 13, 175-182.
3. Carreon, J.D., Morton, L.M., Devesa, S.S., Clarke, C.A., Gomez, S.L., Glaser, S.L., Sakoda, L.C., Linet, M.S. & Wang, S.S. (2008) Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer causes & control: CCC, 19, 1171-1181.
4. Centers for Disease Control and Provention (CDC). (2011) HIV surveillance-United States, 1981-2008. MMWR. Morbidity and mortality weekly report, 60, 689-693.
5. Chihara, D., Ito, H., Matsuda, T., Katanoda, K., Shibata, A., Saika, K., Sobue, T. & Matsuo, K. (2012) Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S. The oncologist, 17, 1547-1550.
6. Clarke, C.A., Undurraga, D.M., Harasty, P.J., Glaser, S.L., Morton, L.M. & Holly, E.A. (2006) Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer epidemiology, biomarkers & prevention, 15, 630-638.
7. Clarke, C.A., Glaser, S.L., Gomez, S.L., Wang, S.S., Keegan, T.H., Yang, J. & Chang, E.T. (2011) Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer epidemiology, biomarkers & prevention, 20, 1064-1077.
8. Clifford, G.M., Polesel, J., Rickenbach, M., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., Fisch, T., Bordoni, A., De Weck, D. & Franceschi, S. (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97, 425-432.
9. Dores, G.M., Devesa, S.S., Curtis, R.E., Linet, M.S. & Morton, L.M. (2012) Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood, 119, 34-43.
10. Engels, E.A., Pfeiffer, R.M., Goedert, J.J., Virgo, P., McNeel, T.S., Scoppa, S.M. & Biggar, R.J. (2006) Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS, 20, 1645-1654.
11. Ferlay, J., Sshin, H., Bray, F., Forman, D., Mathers, C. & Parkin, D. (2010) Cancer Incidence and Mortality Worldwide: IARC CancerBase. International Agency for Research on Cancer, Lyon, France.
12. Glaser, S.L., Clarke, C.A., Gulley, M.L., Craig, F.E., DiGiuseppe, J.A., Dorfman, R.F., Mann, R.B. & Ambinder, R.F. (2003) Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer, 98, 300-309.
13. Grulich, A.E., van Leeuwen, M.T., Falster, M.O. & Vajdic, C.M. (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet, 370, 59-67.
14. Hosgood, H.D. 3rd, Purdue, M.P., Wang, S.S., Zheng, T., Morton, L.M., Lan, Q., Menashe, I., Zhang, Y., Cerhan, J.R., Grulich, A., Cozen, W., Yeager, M., Holford, T.R., Vajdic, C.M., Davis, S., Leaderer, B., Kricker, A., Schenk, M., Zahm, S.H., Chatterjee, N., Chanock, S.J., Rothman, N., Hartge, P. & Armstrong, B. (2011) A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. British journal of haematology, 152, 721-726.
15. Imam, M.H., Shenoy, P.J., Flowers, C.R., Phillips, A. & Lechowicz, M.J. (2013) Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leukemia & lymphoma, 54, 752-759.
16. Jaffe, E., Harris, N., Stein, H. & Vardiman, J. (2001) WHO Classification Tumors of Hematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC), Lyon, France.
17. Kanda, J., Matsuo, K., Inoue, M., Iwasaki, M., Sawada, N., Shimazu, T., Yamaji, T., Sasazuki, S. & Tsugane, S. (2010a) Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study). Cancer epidemiology, biomarkers & prevention, 19, 429-434.
18. Kanda, J., Matsuo, K., Suzuki, T., Hosono, S., Ito, H., Ichinohe, T., Seto, M., Morishima, Y., Tajima, K. & Tanaka, H. (2010b) Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. International journal of cancer. Journal international du cancer, 126, 2416-2425.
19. Kim, H.J., Fay, M.P., Feuer, E.J. & Midthune, D.N. (2000) Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19, 335-351.
20. Kimura, H. (2006) Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Reviews in medical virology, 16, 251-261.
21. Lan, Q., Wang, S.S., Menashe, I., Armstrong, B., Zhang, Y., Hartge, P., Purdue, M.P., Holford, T.R., Morton, L.M., Kricker, A., Cerhan, J.R., Grulich, A., Cozen, W., Zahm, S.H., Yeager, M., Vajdic, C.M., Schenk, M., Leaderer, B., Yuenger, J., Severson, R.K., Chatterjee, N., Chanock, S.J., Zheng, T. & Rothman, N. (2011) Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. British journal of haematology, 153, 341-350.
22. Lim, U., Morton, L.M., Subar, A.F., Baris, D., Stolzenberg-Solomon, R., Leitzmann, M., Kipnis, V., Mouw, T., Carroll, L., Schatzkin, A. & Hartge, P. (2007) Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. American journal of epidemiology, 166, 697-708.
23. Matsuda, A., Matsuda, T., Shibata, A., Katanoda, K., Sobue, T. & Nishimoto, H. (2013) Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Japanese journal of clinical oncology, 43, 328-336.
24. McNally, R.J., Alston, R.D., Cairns, D.P., Eden, O.B. & Birch, J.M. (2003) Geographical and ecological analyses of childhood acute leukaemias and lymphomas in north-west England. British journal of haematology, 123, 60-65.
25. Morton, L.M., Zheng, T., Holford, T.R., Holly, E.A., Chiu, B.C., Costantini, A.S., Stagnaro, E., Willett, E.V., Dal Maso, L., Serraino, D., Chang, E.T., Cozen, W., Davis, S., Severson, R.K., Bernstein, L., Mayne, S.T., Dee, F.R., Cerhan, J.R. & Hartge, P. (2005) Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. The lancet oncology, 6, 469-476.
26. Morton, L.M., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D. & Linet, M.S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265-276.
27. Morton, L.M., Turner, J.J., Cerhan, J.R., Linet, M.S., Treseler, P.A., Clarke, C.A., Jack, A., Cozen, W., Maynadie, M., Spinelli, J.J., Costantini, A.S., Rudiger, T., Scarpa, A., Zheng, T. & Weisenburger, D.D. (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood, 110, 695-708.
28. Morton, L.M., Wang, S.S., Cozen, W., Linet, M.S., Chatterjee, N., Davis, S., Severson, R.K., Colt, J.S., Vasef, M.A., Rothman, N., Blair, A., Bernstein, L., Cross, A.J., De Roos, A.J., Engels, E.A., Hein, D.W., Hill, D.A., Kelemen, L.E., Lim, U., Lynch, C.F., Schenk, M., Wacholder, S., Ward, M.H., Hoar Zahm, S., Chanock, S.J., Cerhan, J.R. & Hartge, P. (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood, 112, 5150-5160.
29. Parkin, D.M. (2006) The evolution of the population-based cancer registry. Nature reviews. Cancer, 6, 603-612.
30. Purdue, M.P., Lan, Q., Wang, S.S., Kricker, A., Menashe, I., Zheng, T.Z., Hartge, P., Grulich, A.E., Zhang, Y., Morton, L.M., Vajdic, C.M., Holford, T.R., Severson, R.K., Leaderer, B.P., Cerhan, J.R., Yeager, M., Cozen, W., Jacobs, K., Davis, S., Rothman, N., Chanock, S.J., Chatterjee, N. & Armstrong, B.K. (2009) A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis, 30, 275-281.
31. Sant, M., Allemani, C., Tereanu, C., De Angelis, R., Capocaccia, R., Visser, O., Marcos-Gragera, R., Maynadie, M., Simonetti, A., Lutz, J.M. & Berrino, F. (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood, 116, 3724-3734.
32. Shiels, M.S., Engels, E.A., Linet, M.S., Clarke, C.A., Li, J., Hall, H.I., Hartge, P. & Morton, L.M. (2013) The Epidemic of Non-Hodgkin Lymphoma in the United States: disentangling the Effect of HIV, 1992-2009. Cancer epidemiology, biomarkers & prevention, 22, 1069-1078.
33. Skibola, C.F. (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer epidemiology, biomarkers & prevention, 16, 392-395.
34. Skibola, C.F., Bracci, P.M., Nieters, A., Brooks-Wilson, A., de Sanjose, S., Hughes, A.M., Cerhan, J.R., Skibola, D.R., Purdue, M., Kane, E., Lan, Q., Foretova, L., Schenk, M., Spinelli, J.J., Slager, S.L., De Roos, A.J., Smith, M.T., Roman, E., Cozen, W., Boffetta, P., Kricker, A., Zheng, T., Lightfoot, T., Cocco, P., Benavente, Y., Zhang, Y., Hartge, P., Linet, M.S., Becker, N., Brennan, P., Zhang, L., Armstrong, B., Smith, A., Shiao, R., Novak, A.J., Maynadie, M., Chanock, S.J., Staines, A., Holford, T.R., Holly, E.A., Rothman, N. & Wang, S.S. (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. American journal of epidemiology, 171, 267-276.
35. Swerdlow, S., Campo, E., Harris, N., Jaffe, E., Pileri, S., Stein, H., Thiele, J. & Vardiman, J. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC), Lyon, France.
36. Wang, S.S., Abdou, A.M., Morton, L.M., Thomas, R., Cerhan, J.R., Gao, X., Cozen, W., Rothman, N., Davis, S., Severson, R.K., Bernstein, L., Hartge, P. & Carrington, M. (2010) Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood, 115, 4820-4823.
37. Yamamoto, J.F. & Goodman, M.T. (2008) Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer causes & control: CCC, 19, 379-390.